TG and ovarian cancer: The published studies have shown that miRNA-130b has a variety of biological functions, including promoting mesenchymal stem cells aging of bladder and colorectal cancer [6, 65], enhancing drug resistance of ovarian cancer cells, enhancing cell motility and downregulating thyroid hormones [66].